Remove Bioequivalency Remove Drugs Remove Pharma Companies Remove Pharmacy
article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

Experts across the board are predicting demand for antiviral drugs will rapidly outpace supply. Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). Reportedly, the cost of production for molnupiravir stands at about $17.74.